The Outcomes and Cost of Therapeutic Interventions in Cardiovascular Patients: A Case Study for Application in Cost-Effectiveness Studies

Background and Aim: Currently, cardiovascular diseases, including coronary heart disease, are one of the leading causes death in humans worldwide. In Eastern Mediterranean Middle East, our country, diseases major health social problems, size which is rapidly increasing. Due to growth medical technologies, population growth, lifestyle changes, studying consequences costs healthcare a critical issue system. This study aimed evaluate outcomes revascularization interventions (angioplasty surgery) therapy patients. Materials Methods: descriptive applied study. Patients after angiography diagnosis according available guidelines were treated by three methods angioplasty (644 patients), surgery (366 (805 patients) public hospital Iran. The data collection tool includes questionnaire collect demographic, clinical cost information Quantitative variables, such as age costs, form Mean±SD, qualitative percentage frequency, presented compared. final result was average direct artery surgery, angioplasty, drug extracted reported using SPSS software. considered complications occurrence death, attack, stroke safety outcome (SO) performing or bypass operation) disease progression confirmed re-angiography effectiveness (EO). Results: Out 1815 patients studied, 790 (43.5%) experienced at least following outcomes, 101 deaths (5.6%), 170 attacks (9.4%), 38 strokes (2.1%), 201 (11%), 116 cases grafting (6.4%), 164 new involvement (9%). frequencies treatment subgroups follows: group, (12.5%), 140 SO (17.3%), 223 EO (27.7%); 97 (15%), 92 (14.3%), 167 (25.9%), surgical (10.4%), 77 (21%), 91 (24.9%). probability for during 8 years 10.2% 9.8%, respectively. Also, re-angioplasty 12.3% 4.3%, respectively, 10.9% 2.5%, (hospitalization) group percutaneous intervention 148 million rials; graft, it 215 rials, therapy, 42 rials. Conclusion: with have more than 43% chance developing within diagnosis. had fewer complications. higher other two treatments. Cardiovascular high heavy economic burdens on society family. Health policymakers can limit resources efficiently effectively expanding screening self-care programs.